Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Sun Pharma may face competition from Eli Lilly’s psoriasis drug

28 March, 2016 1:17 PM
206 0

Eli Lilly has received USFDA nod for Taltz injection, to treat plaque psoriasis, which could pose as a competition to Sun Pharma's skin disease drug.

Sun Pharma was down in trade on Monday because of likely fresh competition for its skin disease drug. Eli Lilly has received US Food and Drug Administration (FDA) nod for Taltz injection to treat plaque psoriasis and hopes to launch the drug this year.

Once Eli Lilly commercialises the product, it could be competition to Sun Pharma’s lead clinical candidate MK-3222.


Share in social networks:

Comments - 0